MS patients on Tysabri (natalizumab) prefer receiving it as a subcutaneous injection, according to data from an observational ...

Mississippians reflect on of how far things have come and how far there still is to go in the medical marijuana business.

Advanced scanning techniques can find hidden inflammation in the brains of multiple sclerosis (MS) patients, a new st ...

Data from the Phase III OCARINA II study shows the subcutaneous version of Ocrevus achieved near-complete suppression of ...

The Food and Drug Administration (FDA) has approved Pivya (pivmecillinam ... women and one of the most frequent reasons for antibiotic use,” said Peter Kim, MD, MS, director of the Division of ...

A new study from Brigham and Women's Hospital suggests that positron emission tomography (PET) brain scans could reveal ...

An earlier start to Ocrevus was linked to slower disability progression over a 10-year period among relapsing and progressive ...

Most doses of Eli Lilly's diabetes drug Mounjaro and weight-loss drug Zepbound would be in limited supply through the second ...

Company announces results from a Phase IV study of Mydcombi designed to characterize the efficacy and duration of the lowest deliverable dose ...